Trakulsrichai Satariya, Kosanyawat Natcha, Atiksawedparit Pongsakorn, Sriapha Charuwan, Tongpoo Achara, Udomsubpayakul Umaporn, Rittilert Panee, Wananukul Winai
Department of Emergency Medicine; Ramathibodi Poison Center.
Department of Emergency Medicine.
Ther Clin Risk Manag. 2017 Mar 14;13:335-340. doi: 10.2147/TCRM.S129610. eCollection 2017.
The objectives of this study were to describe the clinical characteristics and outcomes of poisoning by zinc phosphide, a common rodenticide in Thailand, and to evaluate whether these outcomes can be prognosticated by the clinical presentation.
A 3-year retrospective cohort study was performed using data from the Ramathibodi Poison Center Toxic Exposure Surveillance System.
In total, 455 poisonings were identified. Most were males (60.5%) and from the central region of Thailand (71.0%). The mean age was 39.91±19.15 years. The most common route of exposure was oral (99.3%). Most patients showed normal vital signs, oxygen saturation, and consciousness at the first presentation. The three most common clinical presentations were gastrointestinal (GI; 68.8%), cardiovascular (22.0%), and respiratory (13.8%) signs and symptoms. Most patients had normal blood chemistry laboratory results and chest X-ray findings at presentation. The median hospital stay was 2 days, and the mortality rate was 7%. Approximately 70% of patients underwent GI decontamination, including gastric lavage and a single dose of activated charcoal. In all, 31 patients were intubated and required ventilator support. Inotropic drugs were given to 4.2% of patients. Four moribund patients also received hyperinsulinemia-euglycemia therapy and intravenous hydrocortisone; however, all died. Patients who survived and died showed significant differences in age, duration from taking zinc phosphide to hospital presentation, abnormal vital signs at presentation (tachycardia, low blood pressure, and tachypnea), acidosis, hypernatremia, hyperkalemia, in-hospital acute kidney injury, in-hospital hypoglycemia, endotracheal tube intubation, and inotropic requirement during hospitalization (<0.05).
Zinc phosphide poisoning causes fatalities. Most patients have mild symptoms, and GI symptoms are the most common. Patients who present with abnormal vital signs or electrolytes might have more severe poisoning and should be closely monitored and aggressively treated. All patients should be observed in the hospital for 2 days and followed up for cardiovascular and respiratory symptoms, electrolyte balances, kidney function, and blood glucose.
本研究的目的是描述磷化锌中毒的临床特征和结局,磷化锌是泰国一种常见的灭鼠剂,并评估这些结局是否可通过临床表现进行预测。
利用拉玛蒂博迪中毒中心毒物暴露监测系统的数据进行了一项为期3年的回顾性队列研究。
共识别出455例中毒病例。大多数为男性(60.5%),来自泰国中部地区(71.0%)。平均年龄为39.91±19.15岁。最常见的暴露途径为口服(99.3%)。大多数患者首次就诊时生命体征、血氧饱和度和意识正常。三种最常见的临床表现为胃肠道(GI;68.8%)、心血管(22.0%)和呼吸系统(13.8%)的体征和症状。大多数患者就诊时血液化学实验室检查结果和胸部X线检查结果正常。中位住院时间为2天,死亡率为7%。约70%的患者接受了胃肠道去污处理,包括洗胃和单次剂量的活性炭。共有31例患者进行了气管插管并需要呼吸机支持。4.2%的患者使用了血管活性药物。4例濒死患者还接受了高胰岛素血症-正常血糖疗法和静脉注射氢化可的松;然而,所有患者均死亡。存活和死亡的患者在年龄、服用磷化锌至就诊的时间、就诊时异常生命体征(心动过速、低血压和呼吸急促)、酸中毒、高钠血症、高钾血症、住院期间急性肾损伤、住院期间低血糖、气管插管以及住院期间血管活性药物需求方面存在显著差异(<0.05)。
磷化锌中毒可导致死亡。大多数患者症状较轻,胃肠道症状最为常见。出现异常生命体征或电解质异常的患者可能中毒更严重,应密切监测并积极治疗。所有患者均应在医院观察2天,并对心血管和呼吸系统症状、电解质平衡、肾功能和血糖进行随访。